Cumberland Pharmaceuticals Inc.
CPIX
$4.49
-$0.27-5.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.30% | -42.23% | 44.22% | 69.08% | -499.87% |
| Total Depreciation and Amortization | 27.15% | -1.64% | -0.79% | 5.68% | -8.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.04% | -472.75% | 46.68% | -107.58% | 538.01% |
| Change in Net Operating Assets | 82.25% | 224.36% | 23.17% | -148.05% | 93.06% |
| Cash from Operations | 300.55% | 155.57% | 59.95% | -305.42% | -15.88% |
| Capital Expenditure | 85.06% | -113.89% | 82.69% | 14.58% | 8.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -111.95% | 617.68% | -138.55% | -105.37% | 838.19% |
| Cash from Investing | -114.14% | 505.13% | 19.59% | -122.33% | 374.03% |
| Total Debt Issued | -49.95% | -0.10% | 0.00% | 42.86% | -0.96% |
| Total Debt Repaid | 42.53% | 0.03% | -42.76% | 1.77% | 2.01% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.40% | 26.38% | 45.80% | -31.01% | 6.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.07% | -139.61% | 71.02% | 45.59% | -154.27% |
| Cash from Financing | -156.78% | -73.39% | -112.78% | 262.85% | -68.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 289.24% | 110.59% | -634.16% | 221.79% | -171.96% |